Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$206.39 - $268.73 $57,789 - $75,244
-280 Reduced 82.35%
60 $12.4 Million
Q1 2024

Apr 26, 2024

BUY
$203.52 - $273.43 $4,070 - $5,468
20 Added 6.25%
340 $92.1 Million
Q4 2023

Feb 14, 2024

BUY
$164.52 - $238.84 $52,646 - $76,428
320 New
320 $75.6 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.2B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Systm Wealth Solutions LLC Portfolio

Follow Systm Wealth Solutions LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Systm Wealth Solutions LLC, based on Form 13F filings with the SEC.

News

Stay updated on Systm Wealth Solutions LLC with notifications on news.